Bacille Calmette-Guerin (BCG) vaccine
DISEASE INTERVENTION COMPARISON RESULTS
Neurology. 2014 Jan 7;82(1):41-8 Randomized Controlled Trial
IN multiple sclerosis, first demyelinating attack The Use of
Bacille Calmette-Guerin (BCG) vaccine
As Treatment, Acute
Is better Than
placebo
To reduce at 6 months the number of CNS gadolinium-enhancing lesions and reduce at 5 years the probability of clinically definite multiple sclerosis (HR 0.52)